Association of heart rate variability and inflammatory response in patients with cardiovascular diseases: Current strengths and limitations

Frontiers in Physiology

Volumn 4 JUL, Issue , 2013, Pages

  Papaioannou, Vasilios ^a   Pneumatikos, Ioannis ^a   Maglaveras, Nikos ^b  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Autonomic nervous system; Cardiovascular disease; Coronary artery disease; Heart rate variability; Inflammation; Mortality

Indexed keywords

ATORVASTATIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CARVEDILOL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOCOSAHEXAENOIC ACID; FISH OIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ICOSAPENTAENOIC ACID; INTERLEUKIN 6; OMEGA 3 FATTY ACID; PRAVASTATIN; PROPRANOLOL; SIMVASTATIN; TUMOR NECROSIS FACTOR ALPHA; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; INTERLEUKIN 10;

AUTONOMIC NERVOUS SYSTEM; CARDIOVASCULAR DISEASE; CENTRAL NERVOUS SYSTEM; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; CRITICAL ILLNESS; DISEASE ASSOCIATION; DRUG MECHANISM; ELECTROCARDIOGRAM; FAT INTAKE; HEART ELECTROPHYSIOLOGY; HEART FAILURE; HEART INFARCTION; HEART RATE; HEART RATE VARIABILITY; HIGH FREQUENCY OSCILLATION; HUMAN; HYPERLIPIDEMIA; IMMUNE RESPONSE; INFLAMMATION; LEUKOCYTE COUNT; NONHUMAN; REVIEW; RISK REDUCTION; VAGUS NERVE STIMULATION; ACUTE HEART INFARCTION; BRAIN REGION; CLINICAL EFFECTIVENESS; CYTOKINE PRODUCTION; DIETARY INTAKE; DISEASE MARKER; DRUG EFFICACY; DRUG RESPONSE; HEART VENTRICLE ARRHYTHMIA; IMMUNOREGULATION; NERVE CONDUCTION; PRESSORECEPTOR REFLEX; PROTEIN BLOOD LEVEL; SAFETY; SYMPATHETIC NERVE; SYMPATHETIC TONE; TREATMENT DURATION; VAGUS NERVE;

EID: 84884568367     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2013.00174     Document Type: Review

References (107)

1. Abuissa, H., O'Keefe, J. H., Harris, W. Jr., and Lavie, C. J. (2005). Autonomic function, Omega-3, and cardiovascular risk. Chest 127, 1088-1091.
2. Akselroad, S., Gordon, D., Madwed, J. B., Shannon, D. C., Barger, A. C., and Cohen, R. J. (1981). Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control. Science 213, 220-222.
3. Albert, C. M., Ma, J., Rifai, N., Stampfer, M. J., and Ridker, P. M. (2002). Prospective study of C-reactive protein, homocystein, and plasma lipid levels as predictors of sudden cardiac death. Circulation 105, 2595-2599. doi: 10.1161/01.CIR.0000017493.03108.1C
4. Aronson, D., Mittleman, M. A., and Burger, A. J. (2001). Interleukin-6 levels are inversely correlated with heart rate variability in patients with decompensated heart failure. J. Cardiovasc. Electrophysiol. 12, 294-300. doi: 10.1046/j.1540-8167.2001.00294.x
5. Bernardi, L., Salvucci, F., Suardi, R., Solda, P. L., Salciati, A., Perlini, S., et al. (1990). Evidence for an intrinsic mechanism regulating heart rate variability in the transplanted and the intact heart during submaximal dynamic exercise? Cardiovasc. Res. 24, 969-981. doi: 10.1093/cvr/24.12.969
6. Berthhoud, H. R., and Neuhuber, W. L. (2000). Functional anatomy of afferent vagal system. Auton. Neurosci. 85, 1-17. doi: 10.1016/S1566-0702(00)00215-0
7. Bibevski, S., and Dunlap, M. E. (2011). Evidence for impaired vagus nerve activity in heart failure. Heart Fail Rev. 16, 129-135. doi: 10.1007/s10741-010-9190-6
8. Bilchick, K. C., Fetics, B., Djoukeng, R., Fisher, S. G., Fletcher, R. D., Singh, S. N., et al. (2002). Prognostic value of heart rate variability in chronic congestive heart failure (Veterans Affairs' Survival Trial of Anti-arrhythmic Therapy in Congestive Heart Failure). Am. J. Cardiol. 90, 24-28.
9. Billman, G. E. (2013). The LH/HF ratio does not accurately measure cardiac sympatho-vagal balance. Front. Physiol. 4:26. doi: 10.3389/fphys.2013.00026
10. Billman, G. E. (2012). Effect of dietary omega-3 polyunsaturated fatty acids on heart rate and heart rate variability in animals susceptible or resistant to ventricular fibrillation. Front. Physiol. 3:71. doi: 10.3389/fphys.2012.00071
11. Billman, G. E., and Harris, W. S. (2011). Effect of dietary omega-3 fatty acids on heart rate and the heart rate variability responses to myocardial ischemia or exercise. Am. J. Physiol. Heart Circ. Physiol. 300, H2288-H2299. doi: 10.1152/ajpheart.00140.2011
12. Briest, W., Holzl, A., Raβler, B., Deten, A., Leicht, M., Bada, H. A., et al. (2001). Cardiac remodeling after long term norepinephrine treatment in rats. Cardiovasc. Res. 52, 265-273.
13. Brunner, E. J., Hemingway, H., Walker, B. R., Page, M., Clarke, P., Juneja, M., et al. (2002). Adreno-cortical, autonomic, and inflammatory causes of the metabolic syndrome: nested case-control study. Circulation 106, 2659-2665. doi: 10.1161/01.CIR.0000038364.26310.BD
14. Buchman, T. G. (2002). The community of the self. Nature 420, 246-251. doi: 10.1038/nature01260
15. Calvillo, L., Vanoli, E., Andreoli, E., Besana, A., Omodeo, E., Gneechi, M., et al. (2011). Vagal stimulation, through its nicotinic action limits infarct size and the inflammatory response to myocardial ischemia and reperfusion. J. Cardiovasc. Pharmacol. 58, 500-507. doi: 10.1097/FJC.0b013e31822b7204
16. Christensen, J. H. (2011). Omega-3 polyunsaturated fatty acids and heart rate variability. Front. Physiol. 2:84. doi: 10.3389/fphys.2011.00084
17. Christensen, J. H., Christensen, M. S., Dyerberg, J., and Schmidt, E. B. (1999). Heart rate variability and fatty acid content of blood cell membranes: a dose-response study with n-3 fatty acids. Am. J. Clin. Nutr. 70, 331-337.
18. Chrousos, G. P. (1995). The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. New Engl. J. Med. 332, 1351-1362. doi: 10.1056/NEJM199505183322008
19. Chung, M. K., Gulik, T. S., Rotondo, R. E., Schreiner, G. F., and Lange, L. G. (1990). Mechanisms of action of cytokine inhibition of β-adrenergic agonist stimulation of cyclic AMP in rat cardiac myocytes: impairment of signal transduction. Circ. Res. 67, 753-763. doi: 10.1161/01.RES.67.3.753
20. Commural, C., Singh, K., Pimentel, D. R., and Colucci, W. S. (1998). Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the β-adrenergic pathway. Circulation 98, 1329-1334. doi: 10.1161/01.CIR.98.13.1329
21. DeBoer, R. W., Karemaker, J. M., and Strackee, J. (1987). Hemodynamic fluctuations and baroreflex sensitivity in humans: a beat-to-beat model. Am. J. Physiol. 253, 680-689.
22. De Ferrari, G. M., Crijns, H. J., Borggrefe, M., Milasinovic, G., Smid, J., Zabel, M., et al. (2011). Chronic vagus nerve stimulation: a new and promising therapeutic approach for chronic heart failure. Eur. Heart J. 32, 847-855. doi: 10.1093/eurheartj/ehq391
23. de Jonge, W. J., van der Zanden, E. P., Bijlsma, M. F., van Westerloo, D. J., Bennink, R. J., Berthoud, H. R., et al. (2005). Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway. Nat. Immun. 6, 844-851. doi: 10.1038/ni1229
24. Dekker, J. M., Schouten, E. G., Klootwijk, P., Pool, J, Swenne, C. A., Kromhout, D., et al. (1997). Heart rate variability from short electro-cardiographic recordings predicts mortality from all causes in middle-aged and elderly men. Am. J. Epidemiol. 145, 899-908. doi: 10.1093/oxfordjournals.aje.a009049
25. Eckberg, D. L. (1997). Sympathovagal balance. Circulation 96, 3224-3232. doi: 10.1161/01.CIR.96.9.3224
26. Elenkov, I. J., Wilder, R. L., Chrousos, G. P., and Vizi, E. S. (2000). The sympathetic nerve-an integrative interface between two super-systems: the brain and the immune system. Pharmacol. Rev. 52, 595-638.
27. Fairchild, K. D., Saucerman, J. J., Raynor, L. L., Sivak, J. A., Xiao, Y., Lake, D. E., et al. (2009). Endotoxin depresses heart rate variability in mice: cytokine and steroid effects. Am. J. Physiol. Regul. Integr. Comp. Physiol. 297, 1019-1027. doi: 10.1152/ajpregu.00132.2009
28. Fleckenstein, A. (1971). "Specific inhibitors and promoters of calcium action in the excitation-contraction coupling of heart muscle and their role in the prevention or production of myocardial lesions," in Calcium and the Heart, ed H. P. Opie (London, Academic Press), 135-188.
29. Frasure, S. N., and Lesperance, F. (2006). Depression and coronary artery disease. Herz 31, 64-68.
30. Friedland, J. S., Porter, J. C., Daryanani, S., Bland, J. M., Screaton, N. J., Vesely, M. J., et al. (1996). Plasma proinflammatory cytokine concentrations, APACHE III scores and survival in patients in an intensive care unit. Crit. Care Med. 24, 1775-1781. doi: 10.1097/00003246-199611000-00003
31. Gao, L., Wang, W., Li, Y-L., Schultz, H. D., Liu, D., Cornisch, K. G., et al. (2005). Simvastatin therapy normalizes sympathetic neural control in experimental heart failure. Roles of angiotensin II type 1 receptors and NAD(P)H oxidase. Circulation 112, 1763-1770. doi: 10.1161/CIRCULATIONAHA.105.552174
32. Garder, M. L., and von Karel, R. (2006). Myocardial infarction and post-traumatic stress disorder: frequency, outcome, and atherosclerotic mechanisms. Eur. J. Cardiovasc. Prev. Rehabil. 13, 165-172. doi: 10.1097/01.hjr.0000214606.60995.46
33. Godin, P. J., and Buchman, T. G. (1996). Uncoupling of biological oscillators: a complementary hypothesis concerning the pathogenesis of multiple organ dysfunction syndrome. Crit. Care Med. 24, 1107-1116. doi: 10.1097/00003246-199607000-00008
34. Goldberg, J., Curran, B., Vitek, M. E., Henderson, W. G., and Boyko, E. J. (2002). The vietnam era twin registry. Twin Res. 5, 476-481.
35. Goldberger, A. L. (1996). Non-linear dynamics for clinicians: chaos theory, fractals, and complexity at the bedside. Lancet 347, 1312-1314. doi: 10.1016/S0140-6736(96)90948-4
36. Goldberger, A. L., Amaral, L. A. N., Hausdorff, J. M., Ivanov, P. C., Peng, C. K., and Stanley, H. E. (2002). Fractal dynamics in physiology: alterations with disease and aging. Proc. Natl. Acad. Sci. U.S.A. 99, 2466-2472. doi: 10.1073/pnas.012579499
37. Goldberger, J. J., Challapalli, S., Tung, R., Parker, M. A., and Kadish, A. H. (2001). Relationship of heart rate variability to parasympathetic effect. Circulation 103, 1977-1983. doi: 10.1161/01.CIR.103.15.1977
38. Goldsmith, R. L., Bigger, J. T., Bloomfield, D. M., Krum, H., Steinman, R. C., Sackner-Bernstein, J., et al. (1997). Long-term carvedilol therapy increases parasympathetic nervous system activity in chronic heart failure. Am. J. Cardiol. 80, 1101-1104. doi: 10.1016/S0002-9149(97)00616-4
39. Goldstein, B., and Buchman, T. G. (1998). Heart rate variability in intensive care. Intensive Care Med. 13. 252-265
40. Goldstein, B., Fiser, D. H., Kelly, M. M., Mickelsen, D., Ruttiman, U., and Pollack, M. M. (1998). Decomplexification in critical illness and injury: relationship between heart rate variability, severity of illness, and outcome. Crit. Care Med. 26, 352-557. doi: 10.1097/00003246-199802000-00040
41. Griffin, M. P., Lake, D. E., Bissonette, E. A., Harrell, F. E., Micheal O'Shea, T., et al. (2005). Heart rate characteristics: novel physiomarkers to predict neonatal infection and death. Pediatrics 116, 1070-1074.
42. Haensel, A., Mills, P. J., Nelesen, R. A., Ziegler, M. G., and Dimsdale, J. E. (2008). The relationship between heart rate variability and inflammatory markers in cardio-vascular diseases. Psychoneuroendocrinology 33, 1305-1312. doi: 10.1016/j.psyneuen.2008.08.007
43. Hamaad, A., Sosin, M., Blann, A. D., Patel, J., Lip, G. Y. H., and MacFadyen, R. G. (2005). Markers of inflammation in acute coronary syndromes: association with increased heart rate and reductions in heart rate variability. Clin. Cardiol. 28, 570-576. doi: 10.1002/clc.4960281207
44. Hauptman, P. J., Schwartz, P. J., Gold, M. R., Borggrefe, M., Van Veldhuisen, D. J., Starling, R. C., et al. (2012). Rational and study design of the INcrease Of Vagal TonE in Heart Failure Study: INOVATE-HF. Am. Heart J. 163, 954-962. doi: 10.1016/j.ahj.2012.03.021
45. Hrushesky, W. J., Fader, D., Schmitt, O., and Gilbertsen, V. (1984). The respiratory sinus arrhythmia: a measure of cardiac age. Science 224, 1001-1004. doi: 10.1126/science.6372092
46. Huston, J. M., Ochani, M., Rosas-Ballina, M., Liao, H., Ochani, K., Pavlov, V. A., et al. (2006). Splenectomy inactivates the cholinergic anti-inflammatory pathway during lethal endotoxemia and polymicrobial sepsis. J. Exp. Med. 203, 1623-1628. doi: 10.1084/jem.20052362
47. Janszky, I., Ericson, M., Lekander, M., Blom, M., Buhlin, K., Georgiades, A., et al. (2004). Inflammatory markers and heart rate variability in women with coronary heart disease. J. Intern. Med. 256, 421-428. doi: 10.1111/j.1365-2796.2004.01403.x
48. Kleiger, R. E., Miller, J. P., and Bigger, J. T. (1987). Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am. J. Cardiol. 59, 256-262. doi: 10.1016/0002-9149(87)90795-8
49. Koj, A. (1997). Initiation of acute phase response and synthesis of cytokines. Biochim. Biophys. Acta 1317, 84-94.
50. Kop, W. J., Stein, P. K., Tracy, R. P., Barzilay, J. I., Schulz, R., and Gottdiener, J. S. (2010). Autonomic nervous system dysfunction and inflammation contribute to the increased cardiovascular mortality risk associated with depression. Psychosom. Med. 72, 626-635. doi: 10.1097/PSY.0b013e3181eadd2b
51. Kox, M., Ramakers, B. P., Pompe, J. C., van der Hoeven, J. C., Hoedemaekers, C. W., and Pickkers, P (2011). Interplay between the acute inflammatory response and heart rate variability in healthy human volunteers. Shock 36, 115-120. doi: 10.1097/SHK.0b013e31821c2330
52. La Rovera, M. T., Bigger, J. T., Marcus, F. I., Mortara, A., Maestri, R., and Schwartz, P. J. (1998). Baroreflex sensitivity and heart rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Lancet 351, 478-484. doi: 10.1016/S0140-6736(97)11144-8
53. Lampert, J. R., Ickovics, R., Viscoli, C. J., Horwitz, R. I., and Lee, F. A. (2003). Effects of propranolol on recovery of heart rate variability following acute myocardial infarction and relation to outcome in the beta-blocker heart attack trial. Am. J. Cardiol. 91, 137-142. doi: 10.1016/S0002-9149(02)03098-9
54. Lampert, R., Bremmer, J. D., Su, S., Miller, A., Lee, F., Cheema, F., et al. (2008). Decreased heart rate variability is associated with higher levels of inflammation in middle-aged men. Am. Heart J. 156, 759e1-759e7.
55. Lanfranchi, P. A., and Somers, V. K. (2002). Arterial baroreflex function and cardio-vascular variability: interactions and implications. Am. J. Physiol. Regul. Integr. Comp. Physiol. 283, 815-826.
56. Lanza, G. A., Sgueglia, G. A., Cianflone, D., Rebuzzi, A. G., Angeloni, G., Sestito, A., et al. (2006). Relation of heart rate variability to serum levels of C-reactive protein in patients with unstable angina pectoris. Am. J. Cardiol. 97, 1702-1706. doi: 10.1016/j.amjcard.2006.01.029
57. Lefer, D. J. (2002). Statins as potent anti-inflammatory drugs. Circulation 106, 2041-2042. doi: 10.1161/01.CIR.0000033635.42612.88
58. Li, M., Zheng, C., Sato, T., Kawada, T., Sugimachi, M., and Sunagawa, K. (2004). Vagal nerve stimulation markedly improves long-term survival after chronic heart failure in rats. Circulation 109, 120-124. doi: 10.1161/01.CIR.0000105721.71640.DA
59. Lombardi, F., Sandrone, G., Pernptuner, S., Sala, R., Garimoldi, M., Cerutti, S., et al. (1987). Heart rate variability as an index of sympathovagal interaction after myocardial infarction. Am. J. Cardiol. 60, 1239-1245. doi: 10.1016/0002-9149(87)90601-1
60. Madsen, T., Christensen, J. H., Toft, E., and Schmidt, E. B. (2007). C-reactive protein is associated with heart rate variability. Ann. Noninvasive Electrocardiol. 12, 216-222. doi: 10.1111/j.1542-474X.2007.00164.x
61. Malave, H. A., Taylor, A. A., Nattama, J., Deswal, A., and Mann, D. L. (2003). Circulating levels of tumor necrosis factor correlate with indexes of depressed heart rate variability. Chest 123, 716-724. doi: 10.1378/chest.123.3.716
62. Malik, M., and Camm, A. J. (1993). Components of heart rate variability: what they really mean and what we really measure. Am. J. Cardiol. 72, 821-822 doi: 10.1016/0002-9149(93)91070-X
63. Malpas, S. C. (2002). Neural influences on cardiovascular variability: possibilities and pitfalls. Am. J. Physiol. Heart Circ. Physiol. 282, H6-H20.
64. Mann, D. L., Kent, R. L., Parsons, B., and Cooper, G. (1992). Adrenergic effects on the biology of the adult mammalian cardiocyte. Circulation 85, 790-804. doi: 10.1161/01.CIR.85.2.790
65. Montano, N., Gnecchi-Ruscone, T., Porta, A., Lombardi, F., Malliani, A., and Barman, S. M. (1996). Presence of vasomotor and respiratory rhythms in the discharge of single medullary neurons involved in the regulation of cardiovascular system. J. Auton. Nerv. Syst. 57, 116-122. doi: 10.1016/0165-1838(95)00113-1
66. Mozaffarian, D., Stein, P. K., Prineas, R. J., and Siscovick, D. S. (2008). Dietary Fish ω-3 fatty acid consumption and heart rate variability in US adults. Circulation 117, 1130-1137. doi: 10.1161/CIRCULATIONAHA.107.732826
67. Muller-Werdan, U., Buerke, M., Ebelt, H., Heinroth, K. M., Herklotz, A., Loppnow, H., et al. (2006). Septic cardiomyopathy-a not yet discovered cardiomyopathy? Exp. Clin. Cardiol. 11, 226-236.
68. Nolan, R. P., Reid, G. J., Seidelin, P. H., and Lau, H. K. (2007). C-reactive protein modulates vagal heart rate control in patients with coronary artery disease. Clin. Sci. 112, 449-456. doi: 10.1042/CS20060132
69. Opie, L. H., Walpoth, B., and Barsacchi, R. (1985). Calcium and catecholamines: Rele-vance to cardiomyopathies and significance to therapeutic strategies. J. Mol. Cell Cardiol. 17, 21-34. doi: 10.1016/0022-2828(85)90005-7
70. Owen, N., and Steptoe, A. (2003). Natural killer cell and proinflammatory cytokine responses to mental stress: associations with heart rate and heart rate variability. Biol. Psychol. 63, 101-115. doi: 10.1016/S0301-0511(03)00023-1
71. Papaioannou, V., Dragoumanis, C., Theodorou, V., Gargaretas, C., and Pneumatikos, I. (2009). Relation of heart rate variability to serum levels of C-reactive protein, interleukin 6 and 10 in patients with sepsis and septic shock. J. Crit. Care 24, 625e1-625e7.
72. Phillips, A. N., Neaton, J. D., Cook, D. G., Grimm, R. H., and Shaper, A. G. (1992). Leukocyte count and risk of major coronary heart disease events. Am. J. Epidemiol. 136, 59-70.
73. Pizzi, C., Manzoli, L., Mancini, S., and Maria-Costa, G. (2008). Analysis of potential predictors of depression among coronary heart disease risk factors including heart rate variability, markers of inflammation and endothelial function. Eur. Heart J. 29, 1110-1117. doi: 10.1093/eurheartj/ehn137
74. Pliquett, R. U., Cornish, K. G., and Zucker, I. H. (2002). Statin therapy restores sympathovagal balance in experimental heart failure. J. Appl. Physiol. 95, 700-704.
75. Pontes-Arruda, A., Aragao, A. M., and Albuquerque, J. D. (2006). Effects of enteral feeding with eicosa-pentaenoic acid, gamma-linolenic acid, and anti-oxidants in mechanically ventilated patients with severe sepsis and septic shock. Crit. Care Med. 34, 2325-2333. doi: 10.1097/01.CCM.0000234033.65657.B6
76. Priori, S. G., Aliot, E., Blomstrom-Lundqvist, C., Bossaert, L., Breithardt, G., Brugada, P., et al. (2001). Task force on sudden cardiac death of the european society of cardiology. Eur. Heart J. 16, 1374-1450. doi: 10.1053/euhj.2001.2824
77. Psychari, S. N., Apostolou, T. S., Iliodromitis, E. K., Kourakos, P., Liakos, G., and Kremastinos, D. T. (2007). Inverse relation of C-reactive protein levels to heart rate variability in patients after acute myocardial infarction. Hellenic. J. Cardiol. 48, 64-71.
78. Reichilin, S. (1993). Neuroendocrine-immune interactions. New Engl. J. Med. 329, 1246-1253. doi: 10.1056/NEJM199310213291708
79. Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., and Hennekens, C. H. (1997). Inflammation, aspirin and the risk of cardiovascular disease in apparently healthy men. New Engl. J. Med. 336, 973-979. doi: 10.1056/NEJM199704033361401
80. Rona, G., Chappel, G. I., Balazs, T., and Gaudry, R. (1959). An infarct-like myocardial lesion and other toxic manifestations produced by isoproterenol in the rat. AMA Arch. Pathol. 67, 443-455.
81. Ross, T. (1993). The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362, 801-809. doi: 10.1038/362801a0
82. Sajadieh, A., Nielsen, O. W., Rasmussen, V., Hein, H. O., Abedini, S., and Hansen, J. F. (2004). Increased heart rate and reduced heart-rate variability are associated with subclinical inflammation in middle-aged and elderly subjects with no apparent heart disease. Eur. Heart J. 25, 363-370. doi: 10.1016/j.ehj.2003.12.003
83. Schwartz, P. J., De Ferrari, G. M., Sanzo, A., Landolina, M., Rordorf, R., Raineri, C., et al. (2008). Long term vagal stimulation in patients with advanced heart failure. First experience in man. Eur. J. Heart Fail 10, 884-891. doi: 10.1016/j.ejheart.2008.07.016
84. Seely, A. J. E., and Christou, N. V. (2000). Multiple organ dysfunction syndrome: exploring the paradigm of complex nonlinear systems. Crit. Care Med. 28, 2193-2200. doi: 10.1097/00003246-200007000-00003
85. Shehab, A. M., MacFadyen, R. J., McLaren, M., Tavendale, R., Belch, J. J., and Struthers, A. D. (2004). Sudden unexpected death in heart failure may be preceded by short term, intra-individual increases in inflammation and in autonomic dys-function: a pilot study. Heart 90, 1263-1268. doi: 10.1136/hrt.2003.028399
86. Sherry, R. M., Cue, J. I., Gobbard, J. K., Parramore, J. B., and DiPiro, J. T. (1996). Interleukin-10 is associated with the development of sepsis in trauma patients. J. Trauma. 40, 613-616. doi: 10.1097/00005373-199604000-00016
87. Singer, P., Shapiro, H., Theilla, M., Anbar, R., Singer, J., and Cohen, J. (2008). Anti-inflammatory properties of omega-3 fatty acids in critical illness: novel mechanisms and an integrative perspective. Intensive Care Med. 34, 1580-1592. doi: 10.1007/s00134-008-1142-4
88. Singer, P., Theilla, M., Fisher, H., Gibstein, L., Grozovski, E., and Cohen, J. (2006). Benefit of an enteral diet enriched with eico-sapentaenoic acid and gamma-linolenic acid in ventilated patients with acute lung injury. Crit. Care Med. 34, 1033-1038. doi: 10.1097/01.CCM.0000206111.23629.0A
89. Sloan, R. P., McCreath, H., Tracey, K. J., Sidney, S., Liu, K., and Seeman, T. (2007). RR interval variability is inversely related to inflammatory markers: the CARDIA study. Mol. Med. 13, 178-184.
90. Sporn, M. B. L. (1997). The importance of context in cytokine action. Kidney Int. 51, 1352-1354. doi: 10.1038/ki.1997.184
91. Task Force of the European Society of Cardiology the North American Society of Pacing and Electrophysiology. (1996). Standards of measurement, physio-logical interpretation and clinical use Circulation 93, 1043-1065. doi: 10.1161/01.CIR.93.5.1043
92. Tateishi, Y., Oda, S., Nakamura, M., Watanabe, K., Kuwaki, T., Moriguchi, T., et al. (2007). Depressed heart rate variability is associated with high IL-6 blood level and decline in blood pressure in septic patients. Shock 28, 549-553. doi: 10.1097/shk.0b013e3180638d1
93. Tracey, K. J. (2002). The inflammatory reflex. Nature 420, 853-859. doi: 10.1038/nature01321
94. Tracey, K. J. (2007). Physiology and immunology of the cholinergic anti-inflammatory pathway. J. Clin. Invest. 117, 289-296. doi: 10.1172/JCI30555
95. Tsuji, H., Venditti, F. J., Manders, E. S., Evans, J. C., Larson, M. G., Feldman, C. L., et al. (1994). Reduced heart rate variability and mortality risk in an elderly cohort: the Framingham Heart Study. Circulation 90, 878-883. doi: 10.1161/01.CIR.90.2.878
96. van der Poll, T., Coyle, S. M., Barbosa, K., Braxton, C. C., and Lowry, S. F. (1996). Epinephrine inhibits tumor necrosis factor-α and potentiates interleukin-10 production during human endotoxemia. J. Clin. Invest. 97, 713-719. doi: 10.1172/JCI118469
97. Verkerk, A. O., den Ruijiter, H. M., Bourier, J., Boukens, B. J., Brouwer, I. A., Wilders, R., et al. (2009). Dietary fish oil reduces pacemaker current and heart rate in rabbit. Heart Rhythm 6, 1485-1492. doi: 10.1016/j.hrthm.2009.07.024
98. von Känel, R., Carney, R. M., Zhao, S., and Whooley, M. A. (2011). Heart rate variability and biomarkers of systemic inflammation in patients with stable coronary heart diseases: finding from the Heart and Soul Study. Clin. Res. Cardiol. 100, 241-247. doi: 10.1007/s00392-010-0236-5
99. Vrtovec, B., Okrajsek, R., Golisnik, A., Ferjan, M., Starc, V., and Radovancevic, B. (2005). Atorvastatin therapy increases heart rate variability, decreases QT variability and shortens QTc interval duration in patients with advanced chronic heart failure. J. Card. Fail. 11, 684-690.
100. Wang, H., Liao, H., Ochani, M., Justiniani, M., Lin, X., Yang, L., et al. (2004). Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat. Med. 10, 1216-1221. doi: 10.1038/nm1124
101. Wang, H., Yu, M., Ochani, M., Amella, CA., Tanovic, M., Susarla, S., et al. (2003). Nicotinic acetylcholine receptor α 7 subunit is an essential regulator of inflammation. Nature 421, 384-388. doi: 10.1038/nature01339
102. Webster, J. I., Tonelli, L., and Sternberg, E. M. (2002). Neuroendocrine regulation of immunity. Annu. Rev. Immunol. 20, 125-163. doi: 10.1146/annurev.immunol.20.082401.104914
103. Welzig, C. M., Shin, D.-G., Park, H.-J., Kim, Y. J., Saul, J. P., and Galper, J. B. (2003). Lipid lowering by pravastatin increases parasympathetic modulation of heart rate: G(alpha) i2, a possible molecular marker for parasympathetic responsiveness. Circulation 108, 2743-2746. doi: 10.1161/01.CIR.0000103680.61390.16
104. Wolf, M. M., Varigos, G. A., Hunt, D., and Sloman, J. G. (1978). Sinus arrhythmia in acute myocardial infarction. Med. J. Aust. 2, 52-53.
105. Zaza, A., and Lombardi, F (2001). Autonomic indexes based on the analysis of heart rate variability: a view from the sinus node. Cardiovsc. Res. 50, 434-442. doi: 10.1016/S0008-6363(01)00240-1
106. Zhang, Y., Popovic, Z. B., Bibevski, S., Fakhry, I., Sica, D. A., Van Wagoner, D. R., et al. (2009). Chronic vagus nerve stimulation improves autonomic control and attenuates systemic inflammation and heart failure progression in a canine high-rate pacing model. Circ. Heart Fail 2, 692-699.
107. Zhou, M., Yang, S., Koo, D. J., Ornan, D. A., Chaudry, I. H., and Wang, P. (2001). The role of Kupffer cell α2adrenoceptors in norepinephrine-induced TNF-α production. Biochim. Biophys. Acta 1537, 49-57. doi: 10.1016/S0925-4439(01)00055-2